Objectives: To perform quantitative assessment of the patients’ expectations and satisfaction with cryolipolysis treatment at our facilities.
Introduction: Recently, the development of noninvasive body contouring devices has been remarkable. Among them, cryolipolysis has played a major role in the dramatic expansion of the body contouring and body shaping. At our clinics, the number of cases of cryolipolysis has been increasing year by year. In 2023 (as of November 28), cryolipolysis cases have already reached a record high of 55,896, and our group owns 66 cryolipolysis devices nationwide. In response to such a situation, more trustable data of the patients’ expectations and satisfaction with cryolipolysis is needed.
Materials / method: We started an investigation on the efficacy and safety of cryolipolysis in late June 2023, targeting cryolipolysis models (n = 1,000) at our clinics in Japan. The primary outcomes were adverse events (AEs) that occurred immediately after the procedure, 1 week, 1 month, and 3 months after the procedure, as well as the number of days required for the adverse events to disappear, patient satisfaction with pain, satisfaction with efficacy, and overall satisfaction.
Results: Of 1,000 participants, the data of primary outcomes, AEs disappearing days, various patient satisfaction values etc. At the time of the presentation at IMCAS World Congress 2024, these data will be analyzed and reported with some literature reviews.
Conclusion: Our investigations are ongoing, and we are going to gain further kinds of results from the study, which include not only patients’ satisfaction related data, but details of adverse events caused by cryolipolysis. They will be reported on and on in the future.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。